Cleared Traditional

K080675 - PAJUNK INFILTRALONG WOUND INFILTRATION ...

K080675 is an FDA 510(k) clearance for PAJUNK INFILTRALONG WOUND INFILTRATION ..., manufactured by PAJUNK GmbH Medizintechnologie. The device is a Class 2 Anesthesiology device with product code BSO cleared through the Traditional 510(k) pathway after a 102-day FDA review.

K080675 · PAJUNK GmbH Medizintechnologie · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2008
Decision
102d
Days
Class 2
Risk

K080675 is an FDA 510(k) clearance for the PAJUNK INFILTRALONG WOUND INFILTRATION CATHETER KIT. Classified as Catheter, Conduction, Anesthetic (product code BSO), Class II - Special Controls.

Submitted by PAJUNK GmbH Medizintechnologie (Geisingen, DE). The FDA issued a Cleared decision on June 20, 2008 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5120 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all PAJUNK GmbH Medizintechnologie devices

FDA 510(k) Submission Details - K080675

510(k) Number K080675 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2008
Decision Date June 20, 2008
Days to Decision 102 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 140d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BSO Device Classification - Class 2, Special Controls

Product Code BSO Catheter, Conduction, Anesthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BSO Catheter, Conduction, Anesthetic

All 44
Devices cleared under the same product code (BSO) and FDA review panel - the closest regulatory comparables to K080675.
E-Cath
K152952 · PAJUNK GmbH Medizintechnologie · Jul 2016
Medline Epidural Catheter
K150731 · Medline Industries, Inc. · Mar 2016
PERIFIX ONE PEDIATRIC CATHETER, 20 GA. & 24 GA.
K090884 · B.Braun Medical, Inc. · Jun 2009
BUSSE EPIDURAL CATHETER
K070465 · Busse Hospital Disposables, Inc. · Jul 2007
ON-Q INTRODUCERS
K063234 · I-Flow Corp. · Nov 2006
PORTEX EPIDURAL CATHETER
K062005 · Smiths Medical Asd, Inc. · Oct 2006